METHOD OF SCREENING FOR CANCER USING PARAMETERS OBTAINED BY THE DETECTION OF EARLY INCREASE IN MICROVASCULAR BLOOD CONTENT

• US 20090203977A1
• Filed: 01/08/2009
• Published: 08/13/2009
• Est. Priority Date: 10/27/2005
• Status: Abandoned Application

• Current Assignee: Northshore University Healthsystem (Advocate Aurora Health, Inc.), Northwestern University
• Original Assignee: Northshore University Healthsystem (Advocate Aurora Health, Inc.), Northwestern University
• Inventors: Gomes, Andrew, Ruderman, Sarah, Backman, Vadim, Roy, Hemant, Rogers, Jeremy
• Application Number:
  US12/350,955
• Publication Number:
  US 20090203977A1
• Time in Patent Office: Days
• US Class Current: 600/325
• CPC Class Codes: A61B 1/31 for the rectum, e.g. proctoscopes, sigmoidoscopes , colonoscopes
• CPC Class Codes: A61B 2560/0443 Modular apparatus
• CPC Class Codes: A61B 2562/0242 for varying or adjusting the optical path length in the tissue
• CPC Class Codes: A61B 5/0075 by spectroscopy, i.e. measuring spectra, e.g. Raman spectroscopy, infrared absorption spectroscopy A61B5/0071 takes precedence
• CPC Class Codes: A61B 5/0084 for introduction into the body, e.g. by catheters A61B5/1459 takes precedence
• CPC Class Codes: A61B 5/0261 using optical means, e.g. infrared light
• CPC Class Codes: A61B 5/1459 invasive, e.g. introduced into the body by a catheter A61B5/1464 takes precedence
• CPC Class Codes: A61B 5/4255 Intestines, colon or appendix

Abstract

The present invention, in one aspect, relates to screening test for tumors or lesions using what is referred to as “Early Increase in microvascular Blood Supply” (EIBS) that exists in tissues that are close to, but are not themselves, the abnormal tissue and in tissues that precede the development of such lesions or tumors. While the abnormal tissue can be a lesion or tumor, the abnormal tissue can also be tissue that precedes formation of a lesion or tumor, such as a precancerous adenoma, aberrant crypt foci, tissues that precede the development of dysplastic lesions that themselves do not yet exhibit dysplastic phenotype, and tissues in the vicinity of these lesions or pre-dysplastic tissues.

Claims

1. A method of providing an indication that living tissue within an entire colon of a human body may be abnormal comprising the steps of:

inserting a probe such that a light source within the probe is disposed in a location that is at an inner surface of a distal part of the colon;

illuminating, at the location, tissue of the inner surface of the distal part of the colon and microvasculature within a mucosal layer therein with light from the light source that is emitted from the probe, wherein the tissue that is illuminated with the light does not contain the living tissue that may be abnormal;

detecting interacted light that results from the step of illuminating the tissue as detected data using the probe, wherein the interacted light is obtained substantially from the light that then interacts with blood in the microvasculature of the mucosal layer that is within the tissue of the distal part of the colon, which tissue does not contain the living tissue that may be abnormal;

estimating effective blood vessel size in the microvasculature using the detected data; and

obtaining the indication that the living tissue within the entire colon may be abnormal using the estimated effective blood vessel size.

2. The method according to claim 1 wherein the step of estimating also estimates oxygenated hemoglobin, and wherein the step of obtaining the indication uses both the estimated oxygenated hemoglobin and the estimated blood vessel size.

3. The method according to claim 2 wherein the estimated oxygenated hemoglobin and the estimated blood vessel size are compared against an oxygenated hemoglobin threshold and an estimated blood vessel size threshold, such that the indication that the living tissue within the colon may be abnormal results if and only the estimated blood vessel size is below the estimated blood vessel size threshold and the estimated oxygenated hemoglobin is above the oxygenated hemoglobin threshold.

4. The method according to claim 3 wherein the oxygenated hemoglobin threshold and the estimated blood vessel size threshold are obtained from averages of measurements obtained from a control group of healthy individuals.

5. The method according to claim 4 further including the step of performing a colonoscopy if the indication is that the living tissue may be abnormal.

6. The method according to claim 2 wherein the step of estimating the oxygenated hemoglobin is recalculated using the estimated blood vessel size.

7. The method according to claim 2 wherein a plurality of the estimated oxygenated hemoglobin are obtained from over a period of time, and wherein the step of obtaining the indication includes obtaining a rate of change of estimated hemoglobin using the plurality of the estimated oxygenated hemoglobin.

8. The method according to claim 1 wherein the step of detecting takes place immediately upon contact of the probe with the tissue.

9. The method according to claim 1 wherein the step of detecting takes place a delay period after contact of the probe with the tissue.

10. The method according to claim 1 wherein the step of detecting takes place both immediately upon contact of the probe with the tissue and a delay period after contact of the probe with the tissue.

11. The method according to claim 1 wherein a plurality of the estimated blood vessel sizes are obtained from multiple mucosal depths.

12. The method according to claim 11 wherein a ratio of the estimated blood vessel sizes from different ones of the multiple mucosal depths is used to provide the indication.

13. The method according to claim 1 wherein the step of detecting detects at least one of the following components of the interacted light:

co-polarized, cross-polarized, and unpolarized interacted light.

14. The method according to claim 13 wherein the step of detecting detects interacted light at a plurality of penetration depths between a top of the inner surface to a submucosal layer.

15. The method according to claim 13 wherein the step of detecting the tissue detects interacted light at a plurality of penetration depths between a top of the inner surface to the mucosal layer.

16. The method according to claim 1 wherein the steps of inserting, illuminating and detecting are performed using a probe disposed at least partially within an endoscopic device.

17. The method according to claim 1 wherein the step of obtaining the indication includes the step of comparing the estimated blood vessel size with a baseline vessel size.

18. The method according to claim 17 further including the step of establishing the baseline vessel size.

19. The method according to claim 18 further including the step of establishing the baseline blood vessel size based upon measurements of blood vessel size of a plurality of human bodies other than the human body.

20. The method according to claim 1 wherein the indication from the step of obtaining indicates that the living tissue may be abnormal at a future point in time.

21. The method according to claim 1 further including the step of using the indication to decide when to perform another test to re-determine whether the living tissue within the distal colon may be abnormal.

22. The method according to claim 1 wherein the illuminated tissue is at least one of histologically normal, macroscopically normal, and endoscopically normal.

23. The method according to claim 1 the probe is inserted into the distal colon without any prior colon purging.